Impact of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction hospitalizations: a nationwide analysis

Back

HFA Premium Access

Impact of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction hospitalizations: a nationwide analysis

Session: Heart Failure ePosters - focus on Chronic Heart Failure 5

Topic: Diastolic Ventricular Dysfunction

Speaker: Doctor A. Maraey (Bismarck, US)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Ahmed Maraey

CHI St. Alexius Health Bismarck Medical Center, Bismarck (United States of America)

0 follower

32 more presentations in this session

Comparison 8 vs. 10mm fenestration size of the atrial flow regulator in patients with heart failure with reduced and preserved ejection fraction: an analysis of the Prelieve Trial

Speaker: Doctor C. Paitazoglou (Luebeck, DE)

Access

Abstract

Slides

HDAC6 inhibition reduces cardiac fibrosis, enhances mitochondrial function and demonstrates comparable efficacy as empagliflozin in a mouse model of heart failure with preserved ejection fraction

Speaker: Mr J. Yang (South San Francisco, US)

Access

Abstract

Slides

Improved vascular function after ventricular assist device implantation

Speaker: Doctor D. Nebunu (Zurich, CH)

Access

Abstract

Slides

Left-heart reverse remodeling patterns following treatment with sacubitril/valsartan

Speaker: Doctor A. Abboud (Boston, US)

Access

Abstract

Slides

Identifying distinct clinical subgroups in heart failure with mildly reduced ejection fraction

Speaker: Assistant Professor A. Uijl (Amsterdam, NL)

Access

Abstract

Slides

Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 5

Speakers: Doctor A. Maraey, Doctor C. Paitazoglou, Mr J. Yang, Doctor D. Nebunu, Doctor A. Abboud...

Access

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources